The invention provides a human cyclic GMP phosphodiesterase (PDE9A) and
polynucleotides which identify and encode PDE9A. The invention also
provides expression vectors, host cells, antibodies, agonists, and
antagonists. The invention also provides methods for treating or
preventing disorders associated with expression of PDE9A.